Chelsea A Sheppard
Overview
Explore the profile of Chelsea A Sheppard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sturek J, Thomas T, Gorham J, Sheppard C, Raymond A, Petros de Guex K, et al.
Microbiol Spectr
. 2022 Feb;
10(1):e0256021.
PMID: 35196802
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an unprecedented event requiring frequent adaptation to changing clinical circumstances. Convalescent immune plasma (CIP) is a...
2.
Sturek J, Thomas T, Gorham J, Sheppard C, Raymond A, Petros de Guex K, et al.
medRxiv
. 2021 Feb;
PMID: 33619508
Rationale: The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an unprecedented event requiring rapid adaptation to changing clinical circumstances. Convalescent immune plasma (CIP) is...
3.
Sheppard C, Bolen N, Meny G, Kalvelage M, Ochoa-Garay G
Immunohematology
. 2021 Feb;
36(4):123-128.
PMID: 33544616
In recent years, polymerase chain reaction-based genotyping platforms, which provide a predicted phenotype, have increased in both patient and high-throughput donor testing, especially in situations where serologic methods or reagents...
4.
Sheppard C, Bolen N, Eades B, Ochoa-Garay G, Yazer M
Immunohematology
. 2017 Oct;
33(3):119-124.
PMID: 29043830
Molecular genotyping platforms provide a quick, high-throughput method for identifying red blood cell units for patients on extended phenotype-matching protocols, such as those with sickle cell disease or thalassemia. Most...
5.
Winkler A, Sheppard C, Culler E, Myers R, Duncan A, Castillejo M, et al.
Transfusion
. 2010 May;
50(10):2193-8.
PMID: 20456709
Background: Platelet (PLT) storage adversely affects PLT structure and function in vitro and is associated with decreased PLT recovery and function in vivo. In pediatric transfusion medicine, it is not...
6.
Szlam F, Taketomi T, Sheppard C, Kempton C, Levy J, Tanaka K
Anesth Analg
. 2008 Feb;
106(3):719-24, table of contents.
PMID: 18292408
Background: Thromboembolic complications can occur with recombinant activated factor VII (rFVIIa) treatment in trauma and surgical patients but they are infrequent in hemophiliacs. Bleeding diathesis in these conditions is often...
7.
Taketomi T, Szlam F, Bader S, Sheppard C, Levy J, Tanaka K
Blood Coagul Fibrinolysis
. 2008 Feb;
19(2):135-41.
PMID: 18277134
Thrombin is a key hemostatic enzyme, which propagates its own generation by activating factors V, VIII, and XI. Sustained thrombin generation also activates thrombin-activatable fibrinolysis inhibitor (TAFI), which stabilizes fibrin...
8.
Sheppard C, Logdberg L, Zimring J, Hillyer C
Hematol Oncol Clin North Am
. 2007 Jan;
21(1):163-76.
PMID: 17258125
With the success of reducing the risk of transfusion-transmitted infectious diseases, noninfectious serious hazards of transfusion have come to the forefront with respect to transfusion safety. Transfusion-related acute lung injury...
9.
Sheppard C, OReilly K, Schniederjan S, Hillyer C, Roback J
Transfusion
. 2006 Sep;
46(9):1463-4.
PMID: 16965568
No abstract available.
10.
Sheppard C, Channell C, Ritchie J, Duncan A
Blood Coagul Fibrinolysis
. 2006 Jun;
17(5):425-6.
PMID: 16788322
No abstract available.